Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
3.08 USD | +4.76% | -8.05% | +8.45% |
May. 15 | Transcript : Aytu BioPharma, Inc., Q3 2024 Earnings Call, May 15, 2024 | |
May. 15 | Earnings Flash (AYTU) AYTU BIOPHARMA Reports Q3 Revenue $18M, vs. Street Est of $17.4M | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+8.45% | 16.37M | |
+34.24% | 693B | |
+29.39% | 584B | |
-2.81% | 372B | |
+20.59% | 332B | |
+6.81% | 294B | |
+14.11% | 239B | |
-3.03% | 211B | |
+10.02% | 210B | |
+9.02% | 168B |
- Stock Market
- Equities
- AYTU Stock
- News Aytu BioPharma, Inc.
- Earnings Flash (AYTU) AYTU BIOPHARMA Posts Q4 Revenue $30.7M, vs. Street Est of $27.7M